miR Scientific announces commercial launch of miR Sentinel
miR Sentinel is designed to evaluate the risk of aggressive prostate cancer.
Shalini Nair
Latest articles
All Articles
Microsoft to buy speech recognition firm Nuance for $19.7bn
Microsoft has agreed to buy artificial intelligence (AI) speech recognition firm Nuance Communications in an all-cash deal of $19.7bn.
Boston Scientific starts trial of WATCHMAN FLX LAAC Device
Boston Scientific has begun the CHAMPION-AF clinical trial to analyse the safety and efficacy of the WATCHMAN FLX Left…
Relievant Medsystems completes equity financing
Relievant Medsystems, a US-based medical device company focused on treatment of chronic low back pain (CLBP), has completed a…
Medtronic receives FDA approval for NIM Vital nerve monitoring system
Medtronic has secured Food and Drug Administration (FDA) 510(k) clearance of the NIM Vital nerve monitoring system, which enables…
GeneME develops on-premise FRANKD mouth swab test for Covid-19
Polish biotech company GeneMe has developed FRANKD, a fast, scalable mouth swab test for Covid-19.
India under lockdown for 21 days from midnight of 24 March, says PM Modi
Indian Prime Minister Narendra Modi in a televised address today announced that the entire country will be under lockdown…
Avanos gets FDA clearance for COOLIEF Radiofrequency system
Avanos Medical has secured clearance from the US Food and Drug Administration (FDA) for marketing its 80-Watt COOLIEF Radiofrequency…
Canon Medical gets FDA clearance for Aquilion ONE/PRISM Edition
Canon Medical Systems USA has secured 510(k) clearance from the US Food and Drug Administration (FDA) for the Aquilion…